9,10-dimethyl-1,2-benzanthracene has been researched along with 1-o-hexyl-2,3,5-trimethylhydroquinone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Futakuchi, M; Hirose, M; Miki, T; Ozaki, M; Shirai, T; Tanaka, H | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and 1-o-hexyl-2,3,5-trimethylhydroquinone
Article | Year |
---|---|
Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Ascorbic Acid; Carcinogens; Cell Transformation, Neoplastic; Chemoprevention; Diet; Female; Hydroquinones; Isothiocyanates; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1998 |